Back

Transplanted human photoreceptors differentially survive, incorporate, and mature in mildly and severely degenerated mouse retinae

Pavlou, M.; Tessmer, K.; Hammer, J.; Kurth, T.; Makri, A.; Palitza, C.; Coll San Martin, B.; Rost, F.; Ader, M.

2026-06-23 neuroscience
10.64898/2026.06.18.733059 bioRxiv
Show abstract

Photoreceptor transplantation is considered a disease-agnostic therapeutic strategy for retinal degenerative diseases with highly heterogenous genetic, molecular, and cellular pathologies. While integration of human photoreceptors enriched from stem cell-derived retinal organoids was noted in previous preclinical studies, the potential influence of retinal degeneration severity on transplantation efficiency has not been systematically assessed. Here, we employed mice presenting mild or severe retinal degeneration as recipients for human induced pluripotent stem cell-derived photoreceptors. Donor cells formed multi-cellular clusters that structurally integrated from 3 weeks post-transplantation (wpt) in mildly degenerated retinas, closely interacting with host Muller glia, resulting in proper maturation characterized by inner/outer segment and synapse formation by 26 wpt. In contrast, in severely degenerated hosts, donor photoreceptors remained mainly singularized and scattered in the subretinal space, showing limited structural integration or signs of maturation. Differential maturation of donor cells in mild vs. severe hosts was confirmed by single-cell RNA-sequencing analysis. However, transplantation at the beginning of the degeneration process of the severe model allowed structural integration and maturation of donor photoreceptors, despite complete loss of endogenous photoreceptors over time. The study thus shows that survival, integration, and maturation of donor photoreceptors depend on the degenerative retinal microenvironment shaping significantly transplantation efficiency.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Stem Cell Reports
130 papers in training set
Top 0.1%
33.4%
2
Cells
249 papers in training set
Top 0.1%
6.8%
3
Scientific Reports
3612 papers in training set
Top 16%
5.5%
4
Cell Death & Disease
126 papers in training set
Top 0.6%
3.5%
5
Nature Communications
5641 papers in training set
Top 34%
3.5%
50% of probability mass above
6
Molecular Therapy
81 papers in training set
Top 0.5%
3.5%
7
npj Regenerative Medicine
24 papers in training set
Top 0.2%
2.7%
8
Communications Biology
993 papers in training set
Top 9%
2.4%
9
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 23%
2.1%
10
Cell Stem Cell
62 papers in training set
Top 0.8%
1.9%
11
Molecular Medicine
11 papers in training set
Top 0.1%
1.7%
12
iScience
1154 papers in training set
Top 16%
1.7%
13
eLife
5828 papers in training set
Top 50%
1.7%
14
PLOS ONE
5266 papers in training set
Top 52%
1.3%
15
International Journal of Molecular Sciences
494 papers in training set
Top 10%
1.3%
16
Glia
81 papers in training set
Top 1%
1.1%
17
Molecular Therapy - Methods & Clinical Development
38 papers in training set
Top 0.5%
1.1%
18
Frontiers in Neuroscience
256 papers in training set
Top 5%
1.1%
19
Cell Death Discovery
58 papers in training set
Top 1%
1.1%
20
Aging Cell
165 papers in training set
Top 2%
1.1%
21
Cell Reports
1498 papers in training set
Top 25%
1.0%
22
Stem Cell Research & Therapy
30 papers in training set
Top 0.6%
1.0%
23
EMBO Molecular Medicine
95 papers in training set
Top 2%
1.0%
24
Investigative Ophthalmology & Visual Science
25 papers in training set
Top 0.4%
1.0%
25
Clinical and Translational Science
22 papers in training set
Top 0.6%
0.8%
26
Cell Reports Methods
165 papers in training set
Top 4%
0.6%
27
Frontiers in Cell and Developmental Biology
233 papers in training set
Top 6%
0.6%
28
Science Advances
1243 papers in training set
Top 32%
0.6%
29
Investigative Opthalmology & Visual Science
37 papers in training set
Top 0.5%
0.6%